Neurotron, Incorporated Innovative Medical Technology Established 1981 |
||
Neurometer® CPT®Painless Electrodiagnostic Clinical and LaboratorySensory Nerve Testing Equipment |
The Neurometer® CPT® is a unique neurodiagnostic device that painlessly evalutes the functioning of small unmylenated (C), small myelinated (Aδ) and large myelinated (Aβ) sensory nerve fibers at any cutaneous site. It's sensitive to both hypoesthetic and hyperesthetic abnormalities and more than 800 peer reviewed research publications document its diagnostic capabilities. Since receiving FDA clearance in 1986, more than a million CPT® tests have been conducted around the world
Evaluates more than 90% of sensory nerve fibers (types Aβ, Aδ and C) using a standardized double-blind (p<0.006) automated test procedure . Quantifies hyperesthesia/neuritis through hypoesthesia/neuropathy and monitors the progression of nerve regeneration. Tests distal cutaneous finger and toe sites permiting earliest possible detection of nerve damage from diabetes, carpal tunnel syndrome, spinal injury, sciatica, and radiculopathy, polyneuropathy and other neuropathic conditions. Measures sensory nerve function at any cutaneous site including mucosal surfaces such as the palate and the bladder. CPT® measures are not affected by skin temperature, edema or electromagnetic interference unlike traditional electro-diagnostic and biopsy procedures. Painless, non-invasive and non-aversive procedure is easy to perform and safe and harmless for clinical and laboratory use. Nociceptive, rapid screening, computer automated and manual testing modes are also available. Portable and battery powered device does not require special shielding or environmental conditions. Neuval® CPT® software evaluates measures based on established norms, stores patient test results and prints reports. |